The Vibrating Capsule: Safety and Tolerability in Patients With Chronic Idiopathic Constipation

Area of Science:

• Gastroenterology
• Medical Devices
• Clinical Trials

Background:

• Chronic idiopathic constipation (CIC) is a global health issue with significant disease burden.
• A novel Vibrating Capsule has demonstrated efficacy in treating CIC.
• Detailed safety and tolerability data for this treatment were previously lacking.

Purpose of the Study:

• To comprehensively assess the safety and tolerability of the Vibrating Capsule.
• To analyze adverse events, treatment discontinuation rates, and patient satisfaction.
• To provide detailed safety data for this first-in-class CIC treatment.

Main Methods:

• Post hoc analysis of safety data from six clinical trials (dose-ranging and pivotal studies).
• Inclusion of 800 patients receiving either the active Vibrating Capsule or a sham/placebo.
• Assessment of adverse events, tolerability, and patient satisfaction.

Main Results:

• Low incidence of adverse gastrointestinal events, including bloating, abdominal pain, nausea, and diarrhea.
• Most adverse events were deemed unrelated to treatment; no serious adverse events occurred.
• High patient convenience (83%) and treatment satisfaction (71%); no patients discontinued due to adverse effects.

Conclusions:

• The Vibrating Capsule is a safe and well-tolerated first-in-class treatment for CIC.
• Clinical trial data support its favorable safety profile.
• No treatment discontinuations were reported due to adverse events, indicating good tolerability.